Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.13 - $9.01 $1.18 Million - $5 Million
-554,585 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$6.28 - $15.59 $6.47 Million - $16.1 Million
-1,030,000 Reduced 65.0%
554,585 $4.42 Million
Q4 2021

Feb 14, 2022

SELL
$14.7 - $28.67 $34.4 Million - $67.1 Million
-2,339,156 Reduced 59.62%
1,584,585 $24.2 Million
Q3 2021

Nov 15, 2021

SELL
$24.31 - $33.6 $21.8 Million - $30.1 Million
-895,060 Reduced 18.57%
3,923,741 $112 Million
Q2 2021

Aug 16, 2021

SELL
$26.09 - $40.4 $14.1 Million - $21.9 Million
-541,872 Reduced 10.11%
4,818,801 $163 Million
Q1 2021

May 17, 2021

SELL
$33.06 - $56.93 $63.6 Million - $110 Million
-1,923,793 Reduced 26.41%
5,360,673 $205 Million
Q4 2020

Feb 16, 2021

BUY
$39.09 - $57.4 $285 Million - $418 Million
7,284,466 New
7,284,466 $305 Million
Q1 2020

May 15, 2020

SELL
$7.64 - $27.5 $2.57 Million - $9.25 Million
-336,308 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$15.02 - $20.57 $12.9 Million - $17.7 Million
-861,874 Reduced 71.93%
336,308 $5.43 Million
Q3 2019

Nov 14, 2019

SELL
$18.85 - $27.5 $2.74 Million - $4 Million
-145,309 Reduced 10.82%
1,198,182 $23.1 Million
Q2 2019

Aug 14, 2019

SELL
$17.37 - $26.27 $14.4 Million - $21.8 Million
-828,427 Reduced 38.14%
1,343,491 $31.6 Million
Q1 2019

May 15, 2019

BUY
$10.65 - $25.75 $3.29 Million - $7.94 Million
308,512 Added 16.56%
2,171,918 $50.9 Million
Q4 2018

Feb 14, 2019

BUY
$9.26 - $16.38 $21,353 - $37,772
2,306 Added 0.12%
1,863,406 $20.6 Million
Q3 2018

Nov 14, 2018

SELL
$7.54 - $18.31 $1.21 Million - $2.93 Million
-160,000 Reduced 7.92%
1,861,100 $31.1 Million
Q2 2018

Aug 14, 2018

BUY
$4.87 - $8.42 $827,900 - $1.43 Million
170,000 Added 9.18%
2,021,100 $14.9 Million
Q1 2018

May 15, 2018

SELL
$4.69 - $10.05 $719,446 - $1.54 Million
-153,400 Reduced 7.65%
1,851,100 $8.7 Million
Q4 2017

Feb 14, 2018

BUY
$7.86 - $9.99 $943,200 - $1.2 Million
120,000 Added 6.37%
2,004,500 $18.2 Million
Q3 2017

Nov 14, 2017

BUY
$8.89 - $10.4 $16.8 Million - $19.6 Million
1,884,500
1,884,500 $17.7 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.